2408123-36-2

2408123-36-2 structure
2408123-36-2 structure
  • Name: HDAC-IN-38
  • Chemical Name: HDAC-IN-38
  • CAS Number: 2408123-36-2
  • Molecular Formula: C27H28ClN3O2
  • Molecular Weight: 461.98
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage HDAC
  • Create Date: 2022-07-29 18:45:27
  • Modify Date: 2025-08-26 09:39:58
  • HDAC-IN-38 (compound 13) is a potent HDAC inhibitor. HDAC-IN-38 shows similar micro-molar inhibitory activity toward HDAC1, 2, 3, 5, 6, and 8. HDAC-IN-38 increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy. HDAC-IN-38 also increases the level of histone acetylation (H3K14 or H4K5)[1].

Name HDAC-IN-38
Description HDAC-IN-38 (compound 13) is a potent HDAC inhibitor. HDAC-IN-38 shows similar micro-molar inhibitory activity toward HDAC1, 2, 3, 5, 6, and 8. HDAC-IN-38 increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy. HDAC-IN-38 also increases the level of histone acetylation (H3K14 or H4K5)[1].
Related Catalog
Target

HDAC8:0.533 μM (IC50)

HDAC6:1.27 μM (IC50)

HDAC3:2.86 μM (IC50)

HDAC1:3.82 μM (IC50)

HDAC5:6.27 μM (IC50)

HDAC2:6.62 μM (IC50)

References

[1]. Kaur N, et al. Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment. Eur J Med Chem. 2020 Feb 1;187:111915.

Molecular Formula C27H28ClN3O2
Molecular Weight 461.98
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.